跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMAZYRE 9 mg COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PEMAZYRE 9 mg COMPRIMIDOS
Approved
STANDARD
PEMAZYRE 9 mg COMPRIMIDOS
Incyte Biosciences Distribution B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 7, 2021
Approval ID
c41f2975782f4741
Company
Incyte Biosciences Distribution B.V.
Type
Standard
Approval Details
Approval Id
c41f2975782f4741
Drug Cima Aemps Name
PEMAZYRE 9 mg COMPRIMIDOS
Register Number
1211535003
Holder Company Name
Incyte Biosciences Distribution B.V.
Marketing Company Name
Incyte Biosciences Iberia S.L.
Holder Company Detail Path
/organization/incyte-biosciences-distribution-b-v
Authorization Date
2021-05-07
Dosage Form
COMPRIMIDO
Dose
9 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Incyte Biosciences Distribution B.V.
Company Detail Path
/organization/incyte-biosciences-distribution-b-v
Company Information
Pharmaceutical Company Name
Incyte Biosciences Distribution B.V.
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Active Ingredients
PEMIGATINIB
9 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 7, 2021
Approval ID
c41f2975782f4741
Type
Standard
Back to CIMA-AEMPS Approvals